ArrowMark Financial Corp. Declares $0.15 Monthly Distribution

Liquidia (LQDA) settled all legal disputes with United Therapeutics, ensuring continued access to its PAH treatment YUTREPIA. The company will pay $175M within 30 days and additional payments totaling $205.7M. YUTREPIA sales reached $222.7M in Q3 2026, with LQDA holding $396.1M in cash. GuruFocus values LQDA at $285.40, suggesting a 90.6% undervaluation.

Strive, a Bitcoin treasury company, plans to raise $500M via a new preferred stock offering (SATS) with a 15% fixed dividend. Proceeds will fund Bitcoin purchases, asset acquisitions, or stock buybacks. Strive's Bitcoin holdings are worth ~$2.7B. The company's stock trades under ASST.

Tencent (700 HK) priced USD 1.8bln and CNY 26bln of notes, with net proceeds of approximately USD 1.79bln and CNY 25.89bln. The notes are expected to be issued on October 21st for general corporate purposes.

Kura Oncology (NASDAQ:KURA) launched a $50M venture to develop KO-7246, an oral menin inhibitor for diabetes. Preclinical studies showed improved blood-sugar control in animals and increased beta-cell proliferation in human islet microtissues. The company plans to start clinical trials in 2024, aiming to assess safety and efficacy in diabetes patients.

Microsoft's Azure division is exploring 20% cost cuts, according to a report, to offset AI data center spending and retain talent. The company disputes the characterization, citing routine scenario planning. Azure revenue grew 40% YoY to $101.9B. Leadership changes include Arun Ulag overseeing key cloud units. MSFT stock is up 12% YTD.

Tencent Holdings priced a multi-currency debt offering, issuing $1.8B in USD notes and CNY26B in renminbi notes. Proceeds, estimated at $1.79B and CNY25.89B, will be used for general corporate purposes. The notes are expected to be listed on the Hong Kong Stock Exchange. Tencent is a leading Chinese tech conglomerate with a market cap of HK$3836.4B.